Wednesday, Nov 18, 2026
English News
  • Hyderabad
  • Telangana
  • AP News
  • India
  • World
  • Entertainment
  • Sport
  • Science and Tech
  • Business
  • Rewind
  • ...
    • NRI
    • View Point
    • cartoon
    • My Space
    • Education Today
    • Reviews
    • Property
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • My Space
  • Reviews
  • Education Today
  • Property
  • Lifestyle
Home | Hyderabad | Uoh Granted Patent For Hiv Drug Combination Efficacy Enhancers

UoH granted patent for HIV drug combination efficacy enhancers

Hyderabad: The University of Hyderabad has been granted patent for ‘High active antiretroviral combination drugs loaded lactoferrin nanoparticles for first line and second line therapy’. This has been developed in the laboratory for molecular therapeutics, Department of Biotechnology and Bioinformatics, School of Life Sciences, under the supervision of Prof. Anand K. Kondapi for targeted delivery […]

By Telangana Today
Updated On - 10 December 2021, 03:56 PM
UoH granted patent for HIV drug combination efficacy enhancers
whatsapp facebook twitter telegram

Hyderabad: The University of Hyderabad has been granted patent for ‘High active antiretroviral combination drugs loaded lactoferrin nanoparticles for first line and second line therapy’.

This has been developed in the laboratory for molecular therapeutics, Department of Biotechnology and Bioinformatics, School of Life Sciences, under the supervision of Prof. Anand K. Kondapi for targeted delivery of a combination of antiretroviral drugs to HIV-1 infected cells. The patented technology produces lactoferrin nanoparticles encapsulated in a combination of drugs in first line or second line therapy as a single drug product in an oral capsule for treatment of HIV-1.


Lactoferrin enables carrying of drug cargo through lactoferrin receptor overexpressed HIV-1 infected cells. Due to cooperative loading of the drug combination in the drug product, the drugs are co-delivered in HIV infected cells thus affecting the virus replication by simultaneously acting at the intended targets. Thus, the formulation enhances efficacy of drug combination along with enhanced bioavailability and reduced toxicity.

Said Prof. Kondapi, “Human Immunodeficiency Virus infection (HIV) type 1 infection is associated with development of acquired immunodeficiency syndrome (AIDS). Treatment of HIV involves use of anti-retroviral drugs in various combinations of anti-retroviral drugs in high active antiretroviral therapy (HAART). Major limitations of the current HAART regimen are absence of co-delivery of drug combination to HIV infected cells and unequivocal distribution of drugs in uninfected and infected cells, which leads to low efficacy, emergence of resistance and toxicity.”


Now you can get handpicked stories from Telangana Today on Telegram everyday.

Click the link to subscribe. Click to follow Telangana Today Facebook page and Twitter .

Join Our Whatsapp Channel
  • Follow Us :
As preferred source
  • Tags
  • Anand K. Kondapi
  • HIV
  • Lactoferrin
  • UoH

Related News

  • UoH researchers develop patented nanoformulation for STI prevention, inflammation and contraception

    UoH researchers develop patented nanoformulation for STI prevention, inflammation and contraception

  • UoH secures Rs 2.5 crore in grants for climate-resilient agriculture research

    UoH secures Rs 2.5 crore in grants for climate-resilient agriculture research

  • Rewind: The mystery behind Telangana’s zero-population villages

    Rewind: The mystery behind Telangana’s zero-population villages

  • UoH extends PhD application deadline till May 21

    UoH extends PhD application deadline till May 21

Latest News

  • Editorial: Tread cautiously on data centres

    4 minutes ago
  • Hyderabad Yacht Club wins World Sailing award

    5 minutes ago
  • Andhra gears up for surge in power demand; Naidu orders enhanced preparedness

    10 minutes ago
  • IFL: Sreenidi Deccan FC draws 2-2 against FC Bengaluru United

    13 minutes ago
  • Tolichowki SHO caught red-handed taking Rs 20,000 bribe

    20 minutes ago
  • Hyderabad’s Praanjala ranked ninth among India’s junior badminton players

    29 minutes ago
  • Hyderabad doctor secures affordable rare disease drug for seven children with AHDS

    39 minutes ago
  • Keystone beat Central GST 65-63 in GM Sampath basketball championship

    49 minutes ago

company

  • Home
  • About Us
  • Contact Us
  • Privacy Policy

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

  • Telangana Today Telangana Today
Telangana Today Telangana Today

© Copyrights 2024 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam

Telangana Today App